Skip to content
  • 6,812 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Special notice, women-owned small business set-aside, first published as award notice

Department of Veterans Affairs Pharmaceutical Industry Day

M5Q50A03R8

Department of Veterans Affairs, Nac Federal Supply Schedule. Pharmaceutical Preparation Manufacturing.

9 open like this View on SAM.gov Markdown

Awarded

Wilshire Pharmaceuticals, Inc.

$314,322.29 obligated so far on USAspending

Get the next one like this from Department of Veterans Affairs by email, the day it is posted.Find my opportunities

This one was awarded in 2023

9 like it are open now in pharmaceutical preparation manufacturing

All 9 open in pharmaceutical preparation manufacturing

Description

As published on SAM.gov.

VA Federal Supply Schedule  Greetings Industry, The Department of Veterans Affairs, Enterprise Procurement Office, Office of Acquisition, Logistics, and Construction, in collaboration with the Coalition for Common Sense in Government Procurement, will host a Pharmaceutical Industry Day on November 20, 2026. This one day, in-person event is designed to bring together leaders from both Government and Industry to discuss current developments, challenges, and opportunities within the pharmaceutical sector as they relate to federal procurement. Discussion topics will include updates on policy changes, emerging procurement priorities, and strategies to strengthen collaboration between the VA and its pharmaceutical partners. This event supports ongoing efforts to enhance transparency, communication, and efficiency in the acquisition of pharmaceutical products for our nation s Veterans. Due to limited capacity, registration is limited to two (2) representatives per company and will be approved on a first-come, first-served basis. In advance of this event, all questions pertaining to the subject matter can be submitted to Ms. Regina McGregor, Director of Business Development & Small Business Technical Advisor, EPO, at Regina.McGregor@va.gov. To register to attend, click here: https://www.eventbrite.com/e/va-pharmaceutical-industry-day-tickets-2003087466534?aff=oddtdtcreator&keep_tld=true Thank you, Federal Supply Schedule Services Acquisition Service 5 Enterprise Procurement Office, P.O. Box 76, 1st Avenue, One Block North of 22nd Street, Hines, IL 60141

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Bristol-Myers Squibb Company
UEI
UFGKB2B71N12
CAGE
4K2D9
Vendor location
Lawrenceville, NJ
Contract
36C24924N0470 under 36F79724D0101, delivery order
Obligated
$314,322.29
Actions
1 between May 15, 2024 and May 15, 2024
Competition
Full and Open Competition, 1 offer received
Described as
Abecma
Match
solicitation number 36C24924N0470 was reused as the contract number; same awarding office 36C249 (high confidence)
Record
USAspending award page
Recipient
Bristol-Myers Squibb Company
UEI
UFGKB2B71N12
CAGE
4K2D9
Vendor location
Lawrenceville, NJ
Contract
36C24924N0473 under 36F79724D0101, delivery order
Obligated
$0.00
Actions
2 between May 15, 2024 and November 21, 2024
Competition
Full and Open Competition, 1 offer received
Described as
Breyanzi
Match
solicitation number 36C24924N0473 was reused as the contract number; same awarding office 36C249 (high confidence)
Record
USAspending award page
Recipient
Bristol-Myers Squibb Company
UEI
UFGKB2B71N12
CAGE
4K2D9
Vendor location
Lawrenceville, NJ
Contract
36C24925N0442 under 36F79724D0101, delivery order
Obligated
$0.00
Actions
2 between March 19, 2025 and October 21, 2025
Competition
Full and Open Competition, 1 offer received
Described as
Abecma Inj, Susp, Transplant Treatment, National Drug Code 59572-0515-0.
Match
solicitation number 36C24925N0442 was reused as the contract number; same awarding office 36C249 (high confidence)
Record
USAspending award page
Recipient
Bristol-Myers Squibb Company
UEI
UFGKB2B71N12
CAGE
4K2D9
Vendor location
Lawrenceville, NJ
Contract
36F79724D0101
Obligated
$0.00, potential $26,412,997,461
Actions
54 between April 9, 2024 and August 27, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79724D0101 equals the contract number; same sub-agency 3600 (high confidence)
Record
USAspending award page
Recipient
Zanfel Laboratories, Inc.
UEI
JGFLY125WCJ3
CAGE
3P5J9
Vendor location
Dakota Dunes, SD
Contract
36F79724D0129
Obligated
$0.00, potential $3,782,660
Actions
4 between May 22, 2024 and December 31, 2025
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79724D0129 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Phathom Pharmaceuticals, Inc.
UEI
KPGYDW3H7ZW6
CAGE
9CLZ2
Vendor location
Florham Park, NJ
Contract
36F79724D0154
Obligated
$0.00, potential $250,000
Actions
6 between June 26, 2024 and March 3, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79724D0154 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
First Nation Group LLC
UEI
Z3BPH2N9K1L9
CAGE
74TL4
Vendor location
Niceville, FL
Contract
36F79724D0209
Obligated
$0.00, potential $225,000
Actions
27 between September 12, 2024 and September 3, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79724D0209 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Day One Biopharmaceuticals, Inc.
UEI
G9SZJB5MEHR3
CAGE
9W5Q5
Vendor location
Brisbane, CA
Contract
36F79725D0029
Obligated
$0.00, potential $225,000
Actions
5 between December 6, 2024 and December 1, 2025
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79725D0029 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
National Vitamin Co., Inc.
UEI
HGK4RUB7TMB5
CAGE
45922
Vendor location
Casa Grande, AZ
Contract
36F79725D0126
Obligated
$0.00, potential $33,501,420
Actions
1 between May 12, 2025 and May 12, 2025
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79725D0126 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Bridgebio Pharma, Inc.
UEI
LSA5MDHDB961
CAGE
8FVJ9
Vendor location
Palo Alto, CA
Contract
36F79725D0173
Obligated
$0.00, potential $250,000
Actions
4 between July 11, 2025 and December 10, 2025
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79725D0173 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Soleno Therapeutics Inc.
UEI
DA8ADMFJRDU9
CAGE
72XA4
Vendor location
Redwood City, CA
Contract
36F79725D0187
Obligated
$0.00, potential $225,000
Actions
6 between July 28, 2025 and August 27, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79725D0187 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Ionis Pharmaceuticals, Inc.
UEI
P8PVTLSDNNS6
CAGE
09HU6
Vendor location
Carlsbad, CA
Contract
36F79725D0205
Obligated
$0.00, potential $225,000
Actions
7 between August 13, 2025 and August 26, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79725D0205 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Mesoblast, Inc.
UEI
NNVGHSW7VLM7
CAGE
4QWB3
Vendor location
New York, NY
Contract
36F79726D0079
Obligated
$0.00, potential $225,000
Actions
3 between February 12, 2026 and July 21, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79726D0079 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Neurocrine Biosciences, Inc.
UEI
GMQSH4CZ7EC9
CAGE
5H9C3
Vendor location
San Diego, CA
Contract
36F79726D0128
Obligated
$0.00, potential $6,115,305,300
Actions
1 between May 27, 2026 and May 27, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79726D0128 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page
Recipient
Reckitt Benckiser LLC
UEI
JCJRVJKD1QN4
CAGE
0MWS8
Vendor location
Nutley, NJ
Contract
36F79726D0165
Obligated
$0.00, potential $71,865,680
Actions
1 between August 27, 2026 and August 27, 2026
Competition
Full and Open Competition, 999 offers received
Set-aside reported
No Set Aside Used.
Described as
65 I B, Drugs, Pharmaceuticals, & Hematology Related Products, FSS Contract Award
Match
award number 36F79726D0165 equals the contract number; same awarding office 36F797 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. April 11, 2024

    Award notice

    Bristol Myers Squibb Company Effective: 05-01-2024 to 04-30-2029

    Awarded to Bristol-Myers Squibb Company LAWRENCEVILLE 08648 JIB for $12,278,876,570. SAM.gov, notice d103dcfc6b934895bc6ee514e0eac915

  2. May 15, 2024

    Justification

    626-24-3-2520-0206 - BRISTOL MYERS ABECMA CAR T CELL

    Awarded to Bristol-Myers Squibb Company Lawrenceville 08648 for $314,322. SAM.gov, notice 6bbcb7b6466d487cbcf8c5e38b0d9002

  3. May 15, 2024

    Justification

    626-24-3-2520-0207 - BMS BREYANZI CAR T TRANSPLANT

    Awarded to Bristol-Myers Squibb Company Lawrenceville 08648 for $310,936. SAM.gov, notice d35a04b384794a1b85978b9db63bc244

  4. May 22, 2024

    Award notice

    Zanfel Laboratories, Inc.

    Awarded to Zanfel Laboratories, Inc. Dakota Dunes 57049 SDN for $0. SAM.gov, notice e91af2ea387e4d2693b65f4a6b36cdfb

  5. June 26, 2024

    Award notice

    Phathom Pharmaceuticals, Inc. award date 7/1/2024 to 6/30/2029

    Awarded to Phathom Pharmaceuticals, Inc. Florham Park 07932 Jib for $250,000. SAM.gov, notice c59764f7c61d49148b01d6300c9a4818

  6. September 12, 2024

    Award notice

    First Nation Group, LLC. - Contract Award - Effective 09/15/2024 - 09/14/2029

    Awarded to First Nation Group LLC Niceville 32578 FLK for $0. SAM.gov, notice f67bd75c70114d04be483d89f6baa726

  7. December 6, 2024

    Award notice

    Day One Biopharmaceuticals, Inc. Effective 12/07/2024 - 12/06/2029

    Awarded to Day One Biopharmaceuticals, Inc. Brisbane 94005 for $0. SAM.gov, notice 0f1e15a315c64fdda3e1b563b7aeacc3

  8. March 19, 2025

    Justification

    ABECMA Antineoplastic BCMA directed CAR T cell immunotherapy Delivery Order Justification

    SAM.gov, notice 1a9fecb2286447e180f386296fc0250d

  9. May 12, 2025

    Award notice

    National Vitamin Co., Inc. Effective 05/15/2025 - 05/14/2030

    Awarded to National Vitamin Co., Inc. Casa Grande 85122 Aze for $0. SAM.gov, notice 82b9fb17165a4c3d9f57fb811e7de149

  10. July 11, 2025

    Award notice

    BridgeBio Pharma, Inc. Award date Effective: 7/31/2025 to 7/30/2030

    Awarded to Bridgebio Pharma, Inc. Palo Alto 94304 for $250,000. SAM.gov, notice b5ec559f3ccb4edcbccee76b6ef42dfd

  11. July 28, 2025

    Award notice

    Soleno Therapeutics, Inc. Effective 08/01/2025 - 07/31/2030

    Awarded to Soleno Therapeutics Inc. Redwood City 94065 for $0. SAM.gov, notice a19f72f8ea7844d3a208ea3c32452c61

  12. August 13, 2025

    Award notice

    Ionis Pharmaceuticals, Inc. Effective 8/15/2025 - 8/14/2030

    Awarded to Ionis Pharmaceuticals, Inc. Carlsbad 92010 for $0. SAM.gov, notice 1b43db0c54164554b28f108f48977693

  13. December 10, 2025

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 71119bf2a5834fa48550933de70f345c

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  14. December 10, 2025

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice ecf7d45ba162436c8cfc61900376a1bd

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  15. December 23, 2025

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice b3e84588aee240b78cee3ea9b0f4add7

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  16. February 13, 2026

    Award notice

    Mesoblast, Inc. Contract Award effective 02/15/2026-02/14/2031

    Awarded to Mesoblast, Inc. for $0. SAM.gov, notice b85bb4027d0e486ea0a361d498563362

    2 revisions on SAM
    • April 27, 2026: publish, award notice
    • February 13, 2026: publish, award notice

  17. March 18, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice ca074e23d70d412e8d82a528b318fac7

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  18. April 2, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 89d4f9d241514c1ca0d0ebd48e7e5eca

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  19. April 16, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 2a0c817165984a978e16b4b368f0320e

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  20. April 16, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 3d76005d7be446fe815a35a896805e8d

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  21. April 20, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 2dbd5d44013a4a419565d4f66a644c1a

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  22. April 27, 2026

    Award notice

    Mesoblast, Inc. Contract Award effective 02/15/2026-02/14/2031

    Awarded to Mesoblast, Inc. for $0. SAM.gov, notice 13d9ad5b91c148408e10229d2d18e85d

    2 revisions on SAM
    • April 27, 2026: publish, award notice
    • February 13, 2026: publish, award notice

  23. May 27, 2026

    Award notice

    Neurocrine Biosciences, Inc. Effective 06/01/2026 - 05/31/2031

    Awarded to Neurocrine Biosciences, Inc. for $0. SAM.gov, notice df31f7b5fb11482fa215ab7b80c28739

    1 revisions on SAM
    • May 27, 2026: publish, award notice

  24. June 30, 2026

    Presolicitation

    M5-Q50A-03-R8: 65IB Drugs, Pharmaceuticals & Hematology Related Products Solicitation Refreshment

    Due June 21, 2023 at 1:00 AM EDT. SAM.gov, notice 62eaef0f2f7940b28732946d8e22ca9b

    17 revisions on SAM
    • June 30, 2026: publish, presolicitation
    • April 20, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 16, 2026: publish, presolicitation
    • April 2, 2026: publish, presolicitation
    • March 18, 2026: publish, presolicitation
    • December 23, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 10, 2025: publish, presolicitation
    • December 1, 2022: publish, presolicitation
    • March 31, 2020: publish, presolicitation
    • January 9, 2020: publish, presolicitation
    • October 23, 2019: publish, presolicitation
    • March 29, 2019: publish, presolicitation
    • September 10, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation
    • June 21, 2018: publish, presolicitation

  25. August 27, 2026

    Award notice

    Reckitt Benckiser, LLC Effective 09/01/2026 - 08/31/2031

    Awarded to Reckitt Benckiser LLC for $0. SAM.gov, notice 07677433fafa406d80452e83701086b6

    1 revisions on SAM
    • August 27, 2026: publish, award notice

  26. September 25, 2026

    Award notice

    Wilshire Pharmaceuticals, 36F79726D0208, Schedule 65 I B Effective Dates: 09/29/2026 -09/28/2031

    Awarded to Wilshire Pharmaceuticals, Inc. for $27,200,000. SAM.gov, notice 6bab24d87c564219b599f6e511a3160d

    1 revisions on SAM
    • September 25, 2026: publish, award notice

  27. October 13, 2026

    Special notice

    Due November 20, 2026. SAM.gov, notice 8339c50c5e8a41899065dba197c5d78d

    1 revisions on SAM
    • October 13, 2026: publish, special notice

Points of contact